Search
for
Sort by
Research 211–240 of 776
- Ruxolitinib: A novel molecule in the management of dermatological disorders
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- CS12192 Reverses Alopecia Areata by Selectively Targeting JAK3/JAK1/TBK1.
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Baricitinib as a treatment for myasthenia gravis: A case report
- Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Could baricitinib treat frontal fibrosing alopecia and facial papules?
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature
- Poster Presentations
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Oclacitinib Treatment and Surgical Management in a Case of Periocular Eosinophilic Furunculosis and Vasculitis with Secondary Eyelid Fusion in a Diabetic Cat
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders